You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》里昂:中資股面臨較高回調風險 列策略取向推介名單
里昂上周五發表中國市場量化策略報告表示,中國股市自去年10月以來呈強勁反彈,但該行認為,從市場廣度的角度來看,MSCI中國指數面臨較高的回調風險。 該行指,通過使用股價高於200天移動平均線的公司百分比作為市場寬度的指標分析,該數據在十三周內從5.4%躍升至83.3%,反映出中國離岸股票的反彈強勁。然而,當市場廣度高於75%之時,歷史數據顯示MSCI中國指數平均每周回報率下降0.37%。 里昂按綜合衡量動量的中國股市多因素模型,考量到每股盈利、價格技術、換手率等因素,挑選出中國離岸市場策略取向(Tactical methodology)推介名單,包括中海油服(02883.HK)、綠葉製藥(02186.HK)、康寧傑瑞製藥-B(09966.HK)、京東健康(06618.HK)、愛奇藝(IQ.US)、平安好醫生(01833.HK)、微盟(02013.HK)、新秀麗(01910.HK)、阿里健康(00241.HK)、新東方-S(09901.HK)、海底撈(06862.HK)、中國民航信息網絡(00696.HK)、華晨中國(01114.HK)、唯品會(VIPS.US)及中遠海能(01138.HK)。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account